TY - JOUR
T1 - Inclusivity and diversity
T2 - Integrating international perspectives on stem cell challenges and potential
AU - Fears, Robin
AU - Akutsu, Hidenori
AU - Alentajan-Aleta, Lara Theresa
AU - Caicedo, Andrés
AU - Campos de Carvalho, Antonio Carlos
AU - Čolić, Miodrag
AU - Cornish, Jillian
AU - Cossu, Giulio
AU - Debré, Patrice
AU - Dierckxsens, Geoffrey
AU - El-Badri, Nagwa
AU - Griffin, George
AU - Chingo-Ho Hsieh, Patrick
AU - Inamdar, Maneesha S.
AU - Kumar, Pradeep
AU - Abraham, Consuelo Macias
AU - Maciulaitis, Romaldas
AU - Al Mahtab, Mamun
AU - O'Brien, Fergal J.
AU - Pepper, Michael Sean
AU - Meulen, Volker ter
N1 - Publisher Copyright:
© 2021 The Authors
PY - 2021/8/10
Y1 - 2021/8/10
N2 - Regenerative medicine has great potential. The pace of scientific advance is exciting and the medical opportunities for regeneration and repair may be transformative. However, concerns continue to grow, relating to problems caused both by unscrupulous private clinics offering unregulated therapies based on little or no evidence and by premature regulatory approval on the basis of insufficient scientific rationale and clinical evidence. An initiative by the InterAcademy Partnership convened experts worldwide to identify opportunities and challenges, with a focus on stem cells. This was designed to be inclusive and consensus outputs reflected the diversity of the global research population. Among issues addressed for supporting research and innovation while protecting patients were ethical assessment; pre-clinical and clinical research; regulatory authorization and medicines access; and engagement with patients, policy makers, and the public. The InterAcademy Partnership (IAP) identified options for action for sharing good practice and building collaboration within the scientific community and with other stakeholders worldwide.
AB - Regenerative medicine has great potential. The pace of scientific advance is exciting and the medical opportunities for regeneration and repair may be transformative. However, concerns continue to grow, relating to problems caused both by unscrupulous private clinics offering unregulated therapies based on little or no evidence and by premature regulatory approval on the basis of insufficient scientific rationale and clinical evidence. An initiative by the InterAcademy Partnership convened experts worldwide to identify opportunities and challenges, with a focus on stem cells. This was designed to be inclusive and consensus outputs reflected the diversity of the global research population. Among issues addressed for supporting research and innovation while protecting patients were ethical assessment; pre-clinical and clinical research; regulatory authorization and medicines access; and engagement with patients, policy makers, and the public. The InterAcademy Partnership (IAP) identified options for action for sharing good practice and building collaboration within the scientific community and with other stakeholders worldwide.
KW - biomedical policy
KW - global
KW - regenerative medicine
KW - stem cells
UR - http://www.scopus.com/inward/record.url?scp=85112133403&partnerID=8YFLogxK
U2 - 10.1016/j.stemcr.2021.07.003
DO - 10.1016/j.stemcr.2021.07.003
M3 - Estudio breve
C2 - 34329597
AN - SCOPUS:85112133403
SN - 2213-6711
VL - 16
SP - 1847
EP - 1852
JO - Stem Cell Reports
JF - Stem Cell Reports
IS - 8
ER -